全文获取类型
收费全文 | 145254篇 |
免费 | 12931篇 |
国内免费 | 3171篇 |
专业分类
耳鼻咽喉 | 951篇 |
儿科学 | 2337篇 |
妇产科学 | 1708篇 |
基础医学 | 14245篇 |
口腔科学 | 4436篇 |
临床医学 | 16660篇 |
内科学 | 15817篇 |
皮肤病学 | 1650篇 |
神经病学 | 7936篇 |
特种医学 | 3635篇 |
外国民族医学 | 11篇 |
外科学 | 9391篇 |
综合类 | 19247篇 |
现状与发展 | 10篇 |
一般理论 | 17篇 |
预防医学 | 33932篇 |
眼科学 | 1389篇 |
药学 | 16260篇 |
132篇 | |
中国医学 | 6249篇 |
肿瘤学 | 5343篇 |
出版年
2024年 | 183篇 |
2023年 | 2681篇 |
2022年 | 4122篇 |
2021年 | 6773篇 |
2020年 | 6916篇 |
2019年 | 7200篇 |
2018年 | 6451篇 |
2017年 | 5914篇 |
2016年 | 5377篇 |
2015年 | 5483篇 |
2014年 | 10386篇 |
2013年 | 10949篇 |
2012年 | 9629篇 |
2011年 | 10215篇 |
2010年 | 7775篇 |
2009年 | 7214篇 |
2008年 | 6883篇 |
2007年 | 6761篇 |
2006年 | 5589篇 |
2005年 | 4549篇 |
2004年 | 3770篇 |
2003年 | 3329篇 |
2002年 | 2637篇 |
2001年 | 2446篇 |
2000年 | 1966篇 |
1999年 | 1653篇 |
1998年 | 1409篇 |
1997年 | 1247篇 |
1996年 | 1005篇 |
1995年 | 1038篇 |
1994年 | 984篇 |
1993年 | 773篇 |
1992年 | 728篇 |
1991年 | 602篇 |
1990年 | 514篇 |
1989年 | 512篇 |
1988年 | 442篇 |
1987年 | 381篇 |
1986年 | 306篇 |
1985年 | 629篇 |
1984年 | 653篇 |
1983年 | 474篇 |
1982年 | 504篇 |
1981年 | 453篇 |
1980年 | 394篇 |
1979年 | 343篇 |
1978年 | 279篇 |
1977年 | 201篇 |
1976年 | 207篇 |
1975年 | 145篇 |
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
1.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
2.
3.
《Research in social & administrative pharmacy》2022,18(9):3492-3500
BackgroundPolypharmacy is commonly related to poor drug adherence, decreased quality of life and inappropriate prescribing in eldery. Furthermore, this condition also leads to a higher utilization of health services resources, due to the increased risk of adverse drug events, length of stays in hospitals and readmissions rates after discharge.ObjectiveThis Systematic Review aimed to synthesize the current evidence that evaluates pharmaceutical services on polymedicated patients, from an economic perspective.MethodsSystematic searches were conducted in MEDLINE, SCOPUS and Cochrane Library databases to identify studies that were published until January 2021. Experimental and observational studies were included in this review, using strict inclusion/exclusion criteria and were assessed for quality using the following tools: RoB and ROBINS-I. Two independent reviewers selected the articles and extracted the data.Results3,662 articles were retrieved from the databases. After the screening, 18 studies were included: 9 experimental and 9 observational studies. The studies reported that the integration of the pharmacist as a member of the healthcare team provides an optimized use of pharmacotherapy to polymedicated patients and contributes to health promotion, providing reduction of spending on medication, reduction of expenses related to emergency care and hospitalizations and other medical expenses. The ECRs made cost-effectiveness or cost-benefit analysis, and most of the Non Randomized studies had statistically significant cost savings even considering the expenses of pharmaceutical assistance. Experimental studies reported a cost reduction varying between US$ 193 to US$ 4,966 per patient per year. Furthermore, observational studies estimated a cost reduction of varying from US$ 3 to US$ 2,505 per patient per year. The cost savings are related to decrease in emergency visits and hospitalizations, through pharmacist intervention (medication review and pharmacotherapy follow-up).ConclusionsConsidering the set of studies included, pharmaceutical care services directed to polymedicated patients may cooperate to save financial resources. Most of the interventions showed positive economic trends and also contributed to improving clinical parameters and quality of life. However, due to the majority of the studies having exploratory or qualitative methodology, it is essential to carry out more robust studies, based on full economic evaluation. 相似文献
4.
目的 多样的环境因素使得不同产地栽培滇重楼的化学成分也丰富多样,不同居群栽培滇重楼的甾体皂苷类成分具有很大的差异,多源数据融合分析能更全面的表征药材化学信息,建立一个高效而准确的产地鉴别模型,为其资源合理开发利用提供依据。方法 以来自云南和四川的8个产地(保山、楚雄、大理、红河、丽江、成都、文山、玉溪)共366份栽培滇重楼根茎为实验材料,采集其傅里叶变换近红外光谱(FT-NIR)和衰减全反射-傅里叶变换中红外光谱(ATR-FTMIR)数据。采用Kennard-Stone算法将不同产地的样品分为2/3的训练集和1/3的预测集,基于4种特征变量提取方法(CARS、VIP、SPA、SO-Covsel)结合2种数据融合策略(低级数据融合和中级数据融合),建立偏最小二乘产地判别分析模型。根据模型参数交叉验证均方根误差(RMSECV)和预测均方根误差(RMSEP)评估模型的稳定性,模型训练集和预测集准确率(ACC)评估模型分类性能。结果 近红外光谱和中红外光谱均能反应不同产地栽培滇重楼的化学成分差异,在中级数据融合中,基于VIP和SPA提取的特征变量建立的模型正确率均大于94%。相较于中级数据融合,低级数据融合模型得到了最为满意的结果,其预测集分类正确率达到100%。结论 根据近红外和中红外数据建立的低级数据融合PLS-DA模型,能够用于栽培滇重楼的产地鉴别分析。 相似文献
5.
6.
7.
《Health & place》2022
Racist policies and practices that restrict Black, as compared to white workers, from employment may drive racial inequities in birth outcomes among workers. This study examined the association between structural racism in labor markets, measured at a commuting zone where workers live and commute to work, and low-birthweight birth. We found the deleterious effect of structural racism in labor markets among US-born Southern Black pregnant people of working age, but not among African- or Caribbean-born counterparts in any US region. Our analysis highlights the intersections of structural racism, culture, migration, and history of racial oppression that vary across regions and birth outcomes of Black workers. 相似文献
8.
《Journal of the American Medical Directors Association》2022,23(10):1741.e1-1741.e18
ObjectiveThis study aimed to analyze national influenza infection control policy documents within aged care settings by identifying the consistencies, inconsistencies, and gaps with the current evidence and by evaluating methodological quality. Aged care providers can use these findings to identify their policy documents' strengths and weaknesses.DesignA quality and content analysis of national level policy documents.Setting and ParticipantsAged care settings rely on national agencies' policy recommendations to control and prevent outbreaks. There is limited research on the effectiveness of control measures to prevent and treat influenza within aged care settings. Because of the complexities around aged care governance, the primary responsibility in developing a comprehensive facility-level, infection-prevention policy, falls to the providers.MethodsThe analysis was conducted using the (1) International Appraisal of Guidelines, Research and Evaluation assessment tool, containing 23 items across 6 domains; and the (2) Influenza Related Control Measures in Aged Care settings checklist, developed by the authors, with 82 recommendations covering: medical interventions, nonmedical interventions, and physical layout.ResultsThere were 19 documents from 9 different high-income countries, with a moderately high methodological quality in general. The quality assessment's average score was 40.2% (95% CI 31.9%–44.7%). “Stakeholder involvement” ranked third, and “Editorial independence” and “Rigor of development” had the lowest average scores across all domains. The content analysis' average score was 37.2% (95% CI 10.5%–21.5%). The highest scoring document (59.1%) included term definitions, cited evidence for recommendations, and clear measurable instructions. “Physical Layout” had the least coverage and averaged 21.9% (95% CI 4.2%–37.5%), which shows a substantial gap in built environment recommendations.Conclusions and ImplicationsExisting policy documents vary in their comprehensiveness. The higher scoring documents provide an ideal model for providers. The checklist tools can be used to assess and enhance documents. Further research on document end-user evaluation would be useful, as there is room for improvement in methodological quality and coverage of recommendation coverage, especially related to physical layout. 相似文献
9.
10.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献